Fungal infections in leukemia patients: how do we prevent and treat them?
about
A new tool to quantify receptor recruitment to cell contact sites during host-pathogen interactionPeptides of the constant region of antibodies display fungicidal activityUtility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.The ovarian cancer oncobiome.Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in SingaporeClinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centreEarly Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.Invasive fungal sinusitis of the sphenoid sinus.Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.First report of Westerdykella dispersa as a cause of an angioinvasive fungal infection in a neutropenic host.High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.Usefulness of the computed tomography and magnetic resonance in evaluation of progress of treatment of the neoplasmatic diseases in children.Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity.Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.Invasive fungal infections in acute leukemia.Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia.Genome-Wide Expression Profiling Reveals S100B as Biomarker for Invasive Aspergillosis.Development and evaluation of enzyme-linked immunosorbent assay of nucleic acid sequence-based amplification for diagnosis of invasive aspergillosis.Splenectomy as an effective debulking therapy for disseminated mould infection in acute myeloid leukaemia following adjuvant therapy with interferon gamma and liposomal amphotericin.Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011Detection and investigation of invasive mould disease.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Update on the optimal use of voriconazole for invasive fungal infections.Acute leukaemia: making sense of a complex blood cancer.Treatment principles for the management of mold infections.Difficult diagnosis of invasive fungal infection predominantly involving the lower gastrointestinal tract in acute lymphoblastic leukaemia.The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.Cell surface changes in the Candida albicans mitochondrial mutant goa1Δ are associated with reduced recognition by innate immune cells.Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.Acute myeloid leukemia and the infectious diseases consultant.Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis.Mucor infection: difficult diagnosis.Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.
P2860
Q28539165-BEB8ACCD-2903-44B2-9E89-B2584EA246E3Q28730940-41FC6100-0D78-41A5-85C4-43D71A424A8DQ30583368-8BB4F181-EF6F-41C7-B2CF-7993634DC0F8Q30840066-0CAAC29F-71FA-4D28-86EB-AB24623B90B7Q33829460-7F7C6979-B913-4B43-8E26-3913CA63389BQ33830897-9B14660D-B075-4EB9-80A1-CFDA2D38B6F6Q33913605-4522BEED-6594-4C92-835C-453A5C17618EQ33964833-6E68ED5F-8560-4658-8444-575A20DFDD42Q34052696-B6F7DB24-B627-4F6B-8104-F403A5D4789CQ34054558-297413BE-B7A5-46CB-A396-89DD12E4C981Q34596950-8F49CA9A-6E10-4A23-A928-DC400CDD9DB8Q35036330-9449E243-4625-4F0C-86E9-92D70AD8A914Q35659664-8BBF73EF-3D8A-4C1C-9F6A-CF6FA7CF7C98Q36248595-A19F1FCC-0B09-4990-8CFF-17CB64A1B7C2Q36277727-3E10465E-53AF-4015-845C-35D988D08865Q36311660-56ABB3FF-5DE6-4C4F-AE9F-60588E34F6AFQ36406975-C9CAB5BD-1350-4608-9D42-A7D2172059C2Q36612597-00D53C01-B60C-4822-BB59-553B12217E94Q36696390-5C1FF807-D62C-4357-A674-23EB311EDFA6Q36707560-6CF4532A-B026-4DB9-9047-487A14C9862AQ37317965-551DB9CE-A69B-4386-A12B-1789B8C4A9F6Q37372018-716CFCCE-5D28-413E-955F-A5FCEAB4FC80Q37544662-2B18A583-06E6-4D38-8511-4E7F92CC22BAQ37823011-63A51571-F2EB-4567-A48C-E9C601D4A2EEQ37866827-7B0681DB-8B75-41D4-9345-0BC590BC0D69Q37892901-D5E1288D-F54B-4121-AE05-ABC62F6D9342Q37981504-FA57D221-186A-4A47-8FC0-4AE162BD3307Q38265845-F42EE02D-D718-4F7E-8F38-EF32F5B4BD6AQ38410951-9415C2D8-FAAD-4AD5-9600-859A6C03C71BQ39002810-1F51554B-1884-4F9A-A21B-45CE0C04D71AQ39181204-A9FFB04F-C853-40F5-9884-2EB3737DDEB4Q39785801-2AFA802E-3380-4856-8533-1A71540C52EEQ40039262-B3D71F62-7247-45F7-9532-704630147BAAQ40858856-C99136B4-7DC3-4039-98D1-A064FF26BCDCQ41687058-57071ED2-7F89-4D6E-B761-050725658D0EQ42749863-C246C2E4-73AC-4A7F-82BD-97A2C28BDFECQ43407962-28238DE3-C67E-4101-95C4-0EFE1097A172Q43975147-7F089B0B-9C08-4A47-A448-E63B5526FBF6Q44463574-A4444C31-50E7-4E38-8F3E-05057A3FD921Q47151374-5DC73028-42D3-4667-AC2D-0817FAA9BD0B
P2860
Fungal infections in leukemia patients: how do we prevent and treat them?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fungal infections in leukemia patients: how do we prevent and treat them?
@en
Fungal infections in leukemia patients: how do we prevent and treat them?
@nl
type
label
Fungal infections in leukemia patients: how do we prevent and treat them?
@en
Fungal infections in leukemia patients: how do we prevent and treat them?
@nl
prefLabel
Fungal infections in leukemia patients: how do we prevent and treat them?
@en
Fungal infections in leukemia patients: how do we prevent and treat them?
@nl
P2093
P356
P1476
Fungal infections in leukemia patients: how do we prevent and treat them?
@en
P2093
Dimitrios P Kontoyiannis
Konstantinos Leventakos
Russell E Lewis
P304
P356
10.1086/649879
P407
P577
2010-02-01T00:00:00Z